Potassium Chloride Tablet, Extended Release
NDC Package 59917-047-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Potassium Chloride tablets is a medication a mineral supplement used to treat or prevent low amounts of potassium in the blood. This formulation utilizes a tablet, extended release delivery system. Marketed by Adare Pharmaceuticals Inc, this product is identified by NDC 59917-047.

Identification & Billing

NDC Package Code
59917-047-00
Package Description
1 BAG in 1 DRUM / 39500 TABLET, EXTENDED RELEASE in 1 BAG
Product Code
59917-047
11-Digit Billing Format
59917004700

Clinical Specifications

Proprietary Name
Potassium Chloride
Non-Proprietary Name
Potassium Chloride
Substance Name
Potassium Chloride
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Active Ingredient(s)
POTASSIUM CHLORIDE 1500 mg/1
Usage Information
This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.

Regulatory & Marketing

Labeler Name
Adare Pharmaceuticals Inc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
05-22-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59917-047-00 identifies a specific commercial package of 1 bag in 1 drum / 39500 tablet, extended release in 1 bag of Potassium Chloride (UNFINISHED drug), drug for further processing labeled by Adare Pharmaceuticals Inc. This tablet, extended release is formulated for use and contains potassium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Adare Pharmaceuticals Inc on May 22, 2013. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics.

How is this Adare Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59917004700. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59917-047-00
11-Digit CMS (5-4-2)
59917-0047-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.